Safety and Tolerability of the Chymase Inhibitor Fulacimstat in Patients With Left Ventricular Dysfunction After Myocardial Infarction—Results of the CHIARA MIA 1 Trial

2019 ◽  
Vol 8 (7) ◽  
pp. 942-951 ◽  
Author(s):  
Hans‐Dirk Düngen ◽  
Lars Kober ◽  
Savina Nodari ◽  
Morten Schou ◽  
Christiane Otto ◽  
...  
Keyword(s):  
Myocardial Infarction ◽  
Left Ventricular Dysfunction ◽  
Ventricular Dysfunction ◽  
Left Ventricular ◽  
Chymase Inhibitor

scholarly journals Sodium–glucose co‐transporter 2 inhibition with empagliflozin improves cardiac function in non‐diabetic rats with left ventricular dysfunction after myocardial infarction

2019 ◽  
Vol 21 (7) ◽  
pp. 862-873 ◽  
Author(s):  
Salva R. Yurista ◽  
Herman H.W. Silljé ◽  
Silke U. Oberdorf‐Maass ◽  
Elisabeth‐Maria Schouten ◽  
Mario G. Pavez Giani ◽  
...  
Keyword(s):  
Myocardial Infarction ◽  
Cardiac Function ◽  
Left Ventricular Dysfunction ◽  
Ventricular Dysfunction ◽  
Diabetic Rats ◽  
Left Ventricular

scholarly journals Depression and Risk of Post Myocardial Infarction Left Ventricular Dysfunction

2016 ◽  
Vol 22 (8) ◽  
pp. S60
Author(s):  
Ike S. Okwuosa ◽  
Oluseyi Ojeifo ◽  
Lindsey Hasting-Spaine ◽  
Stuart D. Russell ◽  
Monica Mukherjee ◽  
...  
Keyword(s):  
Myocardial Infarction ◽  
Left Ventricular Dysfunction ◽  
Ventricular Dysfunction ◽  
Left Ventricular ◽  
Post Myocardial Infarction
Sign in / Sign up

Export Citation Format

Share Document